chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccinated Tuesday  07/06/2021 at 12:00pm. At 12:15 I was having palpitations, and my throat felt tight, I attribute this to anxiety, I was nervous to get the shot but think it should still be noted. At 1:00 or 2:00 that afternoon, I noticed about an inch around where the shot was injected I had small white head like bumps, that if scratched or pressured drained white puss. At 3:00pm that afternoon, I stood up from my bed and felt pressure in my head similar to sinus pressure you can get from a cold. I had no congestion.   On Wednesday 07/07/2021 I woke up and my upper L arm was in significant pain. The area that was vaccinated had a 2-3 inch radius that was bright red in color. The area where I was injected had a 0.5-1 inch radius that was dark purple. This area was hot to the touch, firm, and swollen. The pain was constant but worse when touched.    On Thursday 07/08/2021 there was no new symptoms and the skin reaction started to go away but was still present.   Today Friday 07/09/2021 the skin reaction is still present but improved.  It is still painful to the touch. The redness is gone but the dark purple circle is still pressent. It is still slightly firm, and is no longer hot to touch. It is still slightly painful to touch but not bothersome when left alone. Today I had to leave work early due to a drop in blood pressure at 12:00pm. Around 10-11am I was standing and typing when I felt like I had come down with the flu. This happened rapidly within 2 minutes. I felt feverish, I was sweating, I felt nauseous, but I did not vommit, I felt as though I was going to faint. I had one of the nurses at my workplace check my blood pressure. It was 107/72. Within an hour it rose to 108/72 so I decided to go home.  It should be noted I do not normally eat breakfast. I stay well hydrated.  I had only had my medication, and water at the time of this event which is normal for me. I was given crackers, and juice that did not help. I am unsure if this is related to the vaccination but think it should be noted.
Minor reaction on the first day that went away. On the 7th day the injection site is red (2 inch diameter), a little swollen, slight itching.
skin is soft and soaky, skin cleared up from the goosebumps she had since birth; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (skin is soft and soaky, skin cleared up from the goosebumps she had since birth) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (skin is soft and soaky, skin cleared up from the goosebumps she had since birth). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (skin is soft and soaky, skin cleared up from the goosebumps she had since birth) outcome was unknown. Not Provided          No concomitant medications were reported.   This case was linked to MOD-2021-216460 (Patient Link).
Patient received PPD test 1st on left arm; received Gardasil - rt. arm # :30 PM - 8-29-07. Almost passed out immed. upon injection. Body went limp, pale, clammy skin, jerked for a second. Came to very quickly. Rested with feet elevated - cool compress to forehead. BP 100/56 and 94/56. Rested approx. 20 min.
pt recvd vax; pt whinney all afternoon,eve; pt would not eat; t 101; pt given APAP;
2/6/21 she had a rash the size of a tennis ball that was pink in color not red, cough for one day, and chills for one day. The rash was gone as of 2/10/21. Patient states her arm is back to normal and has no questions or concerns.
Increasing erythema and induration over three days, appeared to have cellulitis with lesion 2-3cm in diameter. no fluctuance on exam. Started on Clindamycin for likely MRSA exposure (mother is a healthcare worker).
A cough worsened in May 2021 and I started coughing up blood in July 2021. I had a chest x-ray in July and a 2.5 cm mass was found in my right lung. There is also a small on in my left lung. From there they did a PET scan and found cancer in my left side of my neck, right lung, and in my colon. That is also when they found out I had calcification in my heart. A blockage in my heart was located in September 2021.  I had a stress test done 9/14/2021 and a heart catheterization on 10/6/2021. I have also had cysts appear on my body that I am being treated for.  I still need further testing. My colon issues have not yet been addressed but I am scheduled for a upper GI/ colonoscopy on 11/22/2021.
Patient representative, I believe his wife, called and stated he had a stroke about 1 week after his second dose.  She states he is admitted to Medical center so outcome is unknown.
Information has been received from two healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 04-MAR-2015 the patient was received improperly stored VARIVAX (Merck) (lot # K007979, expiration date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Lightheaded 10 mins after injection.  no LOC. Walked to guerney.    Appeared pale.  able to converse at all times. 14:35  BP 150/59 P 76 and regular, O2 sat 99%.  given water and juice and crackers and felt better within minutes.  no other complaints or severe adverse reaction sxs.  States he did not eat or have fuids since early in day.   14:43 116/64, P 72, O2 sat 100%.   14:50 119/67, P 68 O2 sat 100% 14:55 had cookies.   sitting up.   1504 "back to normal".  good color to skin.  able to stand and ambulate without dizziness 117/71, P 66 and regular, O2 Sat 100%.   Discharged home, ambulatory in very stable condition.
Had a sore arm for several days; Fever 101F; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Had a sore arm for several days) and PYREXIA (Fever 101F) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B22A, 011F21A, 030L20A and 025L20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Ovarian cyst (Had for many years prior to vaccination) and Menopause (Stopped menstruating 3 years ago, way before vaccination). Concomitant products included PROGESTERONE and ESTRADIOL for an unknown indication.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (Had a sore arm for several days). In 2021, the patient experienced PYREXIA (Fever 101F). At the time of the report, PAIN IN EXTREMITY (Had a sore arm for several days) and PYREXIA (Fever 101F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 101 After the second shot, had fever 101F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After the first shot, patient had a sore arm for several days.  After the second shot, patient had a sore arm and fever 101F and took unknown over the counter medicine. Patient was fine after a few days.   After the first booster (dose 3), patient had a sore arm for several days.  After the 2nd booster (dose 4), patient had a sore arm for several days.   This case was linked to (Patient Link).
Transported by ambulance to ER, Memorial Hospital Treated by Internal Medicine MD, Pulmonologist, and Cardiologist.  Treated for Thrombosis, Tachycardia, Difficulty breathing, chest pains and black outs dizzyness gastrointestinal issues bloating cramping, constipation and diarrea umbilical hernia.
her ear was itchy all over, her face was itchy all over, itchy all over again; her body was red,a little red in the face, a little red in the ears; her ear hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (her ear was itchy all over, her face was itchy all over, itchy all over again), ERYTHEMA (her body was red,a little red in the face, a little red in the ears) and FEELING HOT (her ear hot to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced FEELING HOT (her ear hot to touch). On an unknown date, the patient experienced PRURITUS (her ear was itchy all over, her face was itchy all over, itchy all over again) and ERYTHEMA (her body was red,a little red in the face, a little red in the ears). At the time of the report, PRURITUS (her ear was itchy all over, her face was itchy all over, itchy all over again), ERYTHEMA (her body was red,a little red in the face, a little red in the ears) and FEELING HOT (her ear hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 21 Feb 2021, after administration of vaccine, the patient experienced itchy all over, itchy all over the body, a little red in the face and ears, ear hot to touch, her ear and her face was itchy.  Concomitant medications were not provided. Treatment medication included 2 diphenhydramine.
Received MENACTRA and TDAP on 9/7/2010. Came to office on 9/8 with radiating pain from (L) shoulder & (L) arm nauseated, Temp 100. Tenderness to even sl palpation of (L) arm. Sent to ER.
This spontaneous report was received from a nurse practitioner refers to a 19 year old female patient. No relevant medical history of the patient was reported. The patient received the first two doses of GARDASIL over the summer (reported as received the full GARDASIL series over the summer). The reporter was not able to provide the dates of the administration of the first two doses of GARDASIL at the time of the report and it was reported that they were administered at another facility. On 22-SEP-2014, the patient was vaccinated with the third dose of GARDASIL 120 Y (lot number, expiration date, route of administration and site of administration were not reported). There were no concomitant medications reported. On 22-SEP-2014, a PAP smear was also performed and the patient had a positive human papilloma virus (HPV) detection on her PAP smear. The cells in the PAP smear were normal and the type of HPV was not specified at the time of the report. The patient did not report any discomfort or any other adverse effects at the time of the report. There was no product quality complaint (PQC) involved. The outcome of positive HPV detection was unknown. The action taken with GARDASIL was not applicable. The causality of the event was unknown. Additional information has been requested.
Patient was one of our first patients to come to the clinic to get the covid vaccine. name and birthday were checked but honestly the bithday did not register in my mind she was 12.  In the clinic we only do 5-11. The dose for the 5-11 we give is 0.2ml and the 12 and up is suppose to get 0.3.
Patient did not have adverse reaction. She was age 17 at the time of vaccine and it had only been approved for ages 18 and up.
12:45 PM: Severe fatigue, dizziness, eyelids turning red, tunnel vision, headache. 2:00 PM: increased Redness and Swelling around eyes, increased fatigue, headache increasing, small hives breaking out across stomach/torso. Difficulty seeing/blurring vision.
Speech abilities regressed, did not regain previous level of ability for approximately 3 months after influenza vaccine.
she was diagnosed with COVID 5 month after receiving her second shot of the Pfizer Covid Vaccine; she was diagnosed with COVID 5 month after receiving her second shot of the Pfizer Covid Vaccine; This is a spontaneous report from a contactable consumer (patient). This 65-years-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single, dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. Historical vaccine included pneumonia vaccine on 23Aug2021 for immunization. Patient stated 5 month after the 2nd dose of the Pfizer Covid Vaccine she got COVID.  She received pneumonia vaccine 23Aug2021 and had the antibody treatment 29Aug2021 and was told she could not get the booster dose until 90 days after antibody treatment. It has been about 73 days since the antibody treatment. Patient stated she was diagnosed with COVID 5 month after receiving her second shot of the Pfizer Covid Vaccine (purple top). The outcome of the events was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Two and 1/2 days after flu shot, starting about 9:30 am: nausea, dry heaves for 1/2 hour, followed by exhaustion, sleep for 1 hour.  Unsteady feeling for several hours. Okay by afternoon, same day.
This subject is an 81 year old male who according to his wife was admitted to the hospital due to an acute myocardial infarct while enrolled in the RSV 11 study. The subject received RSV vaccine or Placebo and Influenza vaccine on 10/17/02. Subject was admitted to the hospital 284 days post immunization and died 13 days later. Investigator has requested a discharge summary. The myocardial infarction was reported by the investigators as not related to the study vaccine. The death certificate received on 11/20/03 states cardiomyopathy. Follow up on 11/26/03: " Additional information received 11/18/03.  Death Certificate: Date of death: 08/10/03.  Cause of death: PEA arrest due to Global Dilated Cardiomyopathy.  The PEA arrest secondary to Global Dilated Cardiomyoptahy was reported by the Investigator as not related to the study vaccine."
chills; body aches; headache; queasiness; lightheaded; This is a spontaneous report from a non-contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, blood pressure high. The patient was allergic to shellfish (mild).  Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and semaglutide (OZEMPIC) taken from unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 a day after receiving the vaccine, the patient experienced chills, body aches, headache, queasiness and lightheaded. The patient reported that, it lasted for full 8 days and felt normal on day 9 post vaccination. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events chills, body aches, headache, queasiness and lightheaded were resolved on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Fever/raising temperature; Chills; A spontaneous report was received from a consumer, concerning herself, a female patient of unspecified age, who received Moderna's COVID-19 Vaccine and experienced fever/raising temperature/ pyrexia and chills.  The patient's medical history was not provided. Concomitant product use was not provided.  On 05 Jan 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) via unknown route for prophylaxis of COVID-19 infection.    On 06 Jan 2021, after the first dose of vaccine, the patient experienced fever, chills and a raising temperature. Treatment for the events were not provided.   Action taken with mRNA-1273 in response to the events were unknown.   The events, fever/ raising temperature and chills were considered not resolved as it was ongoing at the time of the report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
No adverse effect reported; were inadvertently administered doses of MMR II, that had been improperly stored; Information has been received from a registered nurse referring to a patient of unknown age and gender. Concomitant therapies included sterile diluent. The patient's pertinent medical history, drug reactions/allergies and concurrent condition were not provided.      On 01-JUL-2019 the patient were inadvertently administered doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (therapy type: recombinant human albumin(rHA); lot # R028224, expiration date reported as 04-OCT-2020, but upon internal validation established as 02-OCT-2020; strength, dose and route were not reported) for prophylaxis (product storage error). The administered doses experienced a temperature excursion of 15.9 degree Celsius for 5 hour and 15 minutes. No previous excursions were reported. The temperature excursions were detected by a data logger. No adverse effect was reported.  This is one of five reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA002125: US-009507513-1907USA003025: US-009507513-1907USA003024: US-009507513-1907USA003023:
Red raised itchy rash appeared in an oval around the injection site  3 days after getting the vaccine. The rash cleared up within 48 hours but later appeared again 12 days after getting the vaccine. The second occurrence was much itchier and hot to the touch.  Treated with antihistamine. The second occurrence has lasted 36 hours and counting
I have multiple bruise every where within a week of the vaccine. Also developed internal vibration and muscle jerking all over the body.  Those internal vibration and muscle jerking get worse during my sleep and I have been waken up by them multiple times at night. I'm very fatigue.
Myalgia, Arthralgia, Fever, NauseaVomiting, fatigue Narrative:  Symptoms started post vaccine, returned to work on 2/17/21  Other Relevant History:
Case number PHEH2014US015697 is an initial spontaneous report received from a medical assistant on 01 Aug 2014. This report refers to a 16 year old patient of an unspecified gender. The past medical history and concomitant medications of the patients were not reported. On 25 Jul 2014, the patient was vaccinated with MENVEO (batch number: M13030, expiry date: 30 Sep 2014) at a dose of 0.5 ml intramuscularly which had multiple temperature excursions while in storage. The temperature of the vaccine reached a maximum of 47.5 for one hour and 17 minutes on 18 Jul 2014, a maximum of 47.5 for 42 minutes on 21 Jul 2014, a maximum of 47.5 for one hour and three minutes on 24 Jul 2014 and a maximum of 47.5 for one hour and three minutes on 31 Jul 2014. No adverse events were reported following this maladministration (incorrect storage of drug).
EPISODE BEGAN 5/3 WITH A SORE THROAT AND ALLERGY SYMPTOMS, LOSS OF TASTE AND SMELL ON 5/8, DIARRHEA, NAUSEA, DIZZINESS, HA, COUGH SORE THROAT AND CHILLS
vaccine given to underage patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine given to underage patient) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine given to underage patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine given to underage patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were provided.
On 2/3/19 patient woke up with a fever, headache, dizziness, diarrhea, vomiting, and stomach pains. This went on all day Sunday.  On 2/4/19, patient still had fever, headache, and dizziness. Patient called MD on 2/4/19 with symptoms and they told her it was most likely the vaccine and just continue to rest.  On 2/5/19, felt a little off but feeling better now.
MACULOPAPULAR RASH ON POSTERIOR NECK; ERYTHEMATOUS/EDEMATOUS WHEELS ON RIGHT POSTERIOR AND ANTERIOR SHOULDER EXTENDING DOWN TO RIGHT SIDE OF CHEST, ERYTHEMATOUS/EDEMATOUS WHEELS ON LEFT ARM
Patient began to run a high fever (102 F). I have him Tylenol to reduce the fever, but it only got worse. At one point he had a 103 fever. Usually a very easy going baby, he screamed for two hours that evening. I nursed him all night long and if he moved he would start to cry again. This continued for two days, fever and crying over everything. He developed eczema two days later, severe. All over his little body. He now is constantly covered in excema and is allergic to cows milk. When he has cows milk through my breast milk, he vomits, has diarrhea, and is very uncomfortable.
Admitted to the hospital with Acute appendicitis with localized peritonitis, without perforation or abscess, unspecified whether gangrene present. Tested positive for COVID-19 at this time however, no adverse events were listed
6 inch diameter erythema/warm to touch.  Left anterior thigh and tenderness.
Information has been received from a 60 year old female registered nurse with no known medical history or allergies who was vaccinated SC with a first dose of Zostavax (lot # 656412/1476F). There was no illness at the time of vaccination. Subsequently four days after vaccination, she developed an outbreak of shingles on her neck and left shoulder. Unspecified medical attention was sought. At the time of the report, the nurse was recovering. There was no product quality complaint involved. Additional information indicated that on 24-FEB-2007 at 9 am, the patient developed herpes zoster on the back of her head, down neck on the right and under her chin on right. She was seen by the physician and treated with VALTREX and prednisone. At the time of the report, she was still recovering. The reporter considered the herpes zoster to be an other important medical event. Additional information has been requested.